Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
April 24, 202532m 2s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr Adam M Brufsky, including the following topics:
- Mechanism of action of and long-term data with CDK4/6 inhibitors in the management of metastatic breast cancer (mBC) (0:00)
- Comparing safety profiles of CDK4/6 inhibitors (9:49)
- Role of CDK4/6 inhibitors in therapy for older patients with mBC (24:06)
- Real-world evidence with CDK4/6 inhibitors (27:31)